Published ahead of print on July 21, 2004, doi:10.1164/rccm.200310-1404OC
American Journal of Respiratory and Critical Care Medicine Vol 170. pp. 879-882, (2004)
© 2004 American Thoracic Society
doi: 10.1164/rccm.200310-1404OC
Elevated Plasma Ghrelin Level in Underweight Patients with Chronic Obstructive Pulmonary Disease
Takefumi Itoh,
Noritoshi Nagaya,
Masanori Yoshikawa,
Atsuhiko Fukuoka,
Hideaki Takenaka,
Yoshito Shimizu,
Yoshinori Haruta,
Hideo Oya,
Masakazu Yamagishi,
Hiroshi Hosoda,
Kenji Kangawa and
Hiroshi Kimura
Department of Internal Medicine, National Cardiovascular Center, and Departments of Biochemistry and of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, Osaka; Second Department of Internal Medicine, Nara Medical University, Nara; and Department of Respiratory Medicine, Chugoku Rousai Hospital, Hiroshima, Japan
Correspondence and requests for reprints should be addressed to Noritoshi Nagaya, M.D., Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka 565-8565, Japan. E-mail: nagayann{at}hsp.ncvc.go.jp
Ghrelin, a novel growth hormonereleasing peptide, has been shown to cause a positive energy balance by reducing fat use and stimulating food intake. This study investigated whether plasma ghrelin is associated with clinical parameters in patients with chronic obstructive pulmonary disease. Plasma ghrelin was measured in 50 patients and 13 control subjects, together with anabolic and catabolic factors. Patients were divided into two groups based on body mass index: underweight patients (n = 26) or normal weight patients (n = 24). Plasma ghrelin was significantly higher in underweight patients than in normal weight patients and healthy control subjects. Circulating tumor necrosis factor- , interleukin-6, and norepinephrine were significantly higher in underweight patients than in normal weight patients. Plasma ghrelin correlated negatively with body mass index and correlated positively with catabolic factors such as tumor necrosis factor- and norepinephrine. In addition, plasma ghrelin correlated positively with percent predicted residual volume and residual volume-to-total lung capacity ratio. In conclusion, plasma ghrelin was elevated in underweight patients with chronic obstructive pulmonary disease, and the level was associated with a cachectic state and abnormality of pulmonary function.
Key Words: cachexia ghrelin hormone pulmonary disease, chronic obstructive
This article has been cited by other articles:

|
 |

|
 |
 
F. Laghi, N. Adiguzel, and M. J. Tobin
Endocrinological derangements in COPD
Eur. Respir. J.,
October 1, 2009;
34(4):
975 - 996.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes and B. R. Celli
Systemic manifestations and comorbidities of COPD
Eur. Respir. J.,
May 1, 2009;
33(5):
1165 - 1185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mineo, V. Ambrogi, L. Frasca, M. E. Cufari, E. Pompeo, and T. C. Mineo
Effects of Lung Volume Reduction Surgery for Emphysema on Glycolipidic Hormones
Chest,
July 1, 2008;
134(1):
30 - 37.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Wagner
Possible mechanisms underlying the development of cachexia in COPD
Eur. Respir. J.,
March 1, 2008;
31(3):
492 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sato, M. Takeno, K. Honma, H. Yamauchi, Y. Saito, T. Sasaki, H. Morikubo, Y. Nagashima, S. Takagi, K. Yamanaka, et al.
Heme Oxygenase-1, a Potential Biomarker of Chronic Silicosis, Attenuates Silica-induced Lung Injury
Am. J. Respir. Crit. Care Med.,
October 15, 2006;
174(8):
906 - 914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. O. Mundinger, D. E. Cummings, and G. J. Taborsky Jr
Direct Stimulation of Ghrelin Secretion by Sympathetic Nerves
Endocrinology,
June 1, 2006;
147(6):
2893 - 2901.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
November 1, 2005;
172(9):
1105 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Zaloga
Ghrelin, Diet, and Pulmonary Function
Chest,
September 1, 2005;
128(3):
1084 - 1086.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|